Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats: effect of ganglioside treatment

P. Marini, M. Vitadello, R. Bianchi, C. Triban, A. Gorio

Research output: Contribution to journalArticle

Abstract

The anterograde and retrograde axonal flow of acetylcholinesterase were studied in the sciatic nerve of alloxandiabetic rats after five weeks of experimental diabetes. A slight reduction of the anterograde axonal flow of the enzyme was found in alloxan-diabetic compared to control rats. Sedimentation analysis revealed a major reduction of anterograde axonal flow of the light globular forms of the enzyme (G1 +G2), which are probably conveyed by slow transport. There was also a minor reduction of the anterograde flow of the globular form G4, while no modification of the axonal flow of the heavy asymmetric form A12 was found. Both G4 and A12 molecular forms are conveyed by fast axonal transport. In contrast, no abnormality of the retrograde axonal flow of acetylcholinesterase was observed. Ganglioside treatment antagonized the decline of the anterograde axonal flow of the enzyme in alloxan-diabetic rats. These results are consistent with the view that experimental diabetic neuropathy is associated with axonal transport defects, and suggest a protective effect of ganglioside treatment against neuronal damage(s) related to the diabetic syndrome.

Original languageEnglish
Pages (from-to)254-258
Number of pages5
JournalDiabetologia
Volume29
Issue number4
DOIs
Publication statusPublished - Apr 1986

Fingerprint

Alloxan
Axonal Transport
Gangliosides
Sciatic Nerve
Acetylcholinesterase
compound A 12
Enzymes
Diabetic Neuropathies
Therapeutics
Light

Keywords

  • acetylcholinesterase
  • Axonal transport
  • experimental diabetic neuropathy
  • gangliosides

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats : effect of ganglioside treatment. / Marini, P.; Vitadello, M.; Bianchi, R.; Triban, C.; Gorio, A.

In: Diabetologia, Vol. 29, No. 4, 04.1986, p. 254-258.

Research output: Contribution to journalArticle

Marini, P. ; Vitadello, M. ; Bianchi, R. ; Triban, C. ; Gorio, A. / Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats : effect of ganglioside treatment. In: Diabetologia. 1986 ; Vol. 29, No. 4. pp. 254-258.
@article{ce2944b2cf344b24bb4e9e1af729e295,
title = "Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats: effect of ganglioside treatment",
abstract = "The anterograde and retrograde axonal flow of acetylcholinesterase were studied in the sciatic nerve of alloxandiabetic rats after five weeks of experimental diabetes. A slight reduction of the anterograde axonal flow of the enzyme was found in alloxan-diabetic compared to control rats. Sedimentation analysis revealed a major reduction of anterograde axonal flow of the light globular forms of the enzyme (G1 +G2), which are probably conveyed by slow transport. There was also a minor reduction of the anterograde flow of the globular form G4, while no modification of the axonal flow of the heavy asymmetric form A12 was found. Both G4 and A12 molecular forms are conveyed by fast axonal transport. In contrast, no abnormality of the retrograde axonal flow of acetylcholinesterase was observed. Ganglioside treatment antagonized the decline of the anterograde axonal flow of the enzyme in alloxan-diabetic rats. These results are consistent with the view that experimental diabetic neuropathy is associated with axonal transport defects, and suggest a protective effect of ganglioside treatment against neuronal damage(s) related to the diabetic syndrome.",
keywords = "acetylcholinesterase, Axonal transport, experimental diabetic neuropathy, gangliosides",
author = "P. Marini and M. Vitadello and R. Bianchi and C. Triban and A. Gorio",
year = "1986",
month = "4",
doi = "10.1007/BF00454886",
language = "English",
volume = "29",
pages = "254--258",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats

T2 - effect of ganglioside treatment

AU - Marini, P.

AU - Vitadello, M.

AU - Bianchi, R.

AU - Triban, C.

AU - Gorio, A.

PY - 1986/4

Y1 - 1986/4

N2 - The anterograde and retrograde axonal flow of acetylcholinesterase were studied in the sciatic nerve of alloxandiabetic rats after five weeks of experimental diabetes. A slight reduction of the anterograde axonal flow of the enzyme was found in alloxan-diabetic compared to control rats. Sedimentation analysis revealed a major reduction of anterograde axonal flow of the light globular forms of the enzyme (G1 +G2), which are probably conveyed by slow transport. There was also a minor reduction of the anterograde flow of the globular form G4, while no modification of the axonal flow of the heavy asymmetric form A12 was found. Both G4 and A12 molecular forms are conveyed by fast axonal transport. In contrast, no abnormality of the retrograde axonal flow of acetylcholinesterase was observed. Ganglioside treatment antagonized the decline of the anterograde axonal flow of the enzyme in alloxan-diabetic rats. These results are consistent with the view that experimental diabetic neuropathy is associated with axonal transport defects, and suggest a protective effect of ganglioside treatment against neuronal damage(s) related to the diabetic syndrome.

AB - The anterograde and retrograde axonal flow of acetylcholinesterase were studied in the sciatic nerve of alloxandiabetic rats after five weeks of experimental diabetes. A slight reduction of the anterograde axonal flow of the enzyme was found in alloxan-diabetic compared to control rats. Sedimentation analysis revealed a major reduction of anterograde axonal flow of the light globular forms of the enzyme (G1 +G2), which are probably conveyed by slow transport. There was also a minor reduction of the anterograde flow of the globular form G4, while no modification of the axonal flow of the heavy asymmetric form A12 was found. Both G4 and A12 molecular forms are conveyed by fast axonal transport. In contrast, no abnormality of the retrograde axonal flow of acetylcholinesterase was observed. Ganglioside treatment antagonized the decline of the anterograde axonal flow of the enzyme in alloxan-diabetic rats. These results are consistent with the view that experimental diabetic neuropathy is associated with axonal transport defects, and suggest a protective effect of ganglioside treatment against neuronal damage(s) related to the diabetic syndrome.

KW - acetylcholinesterase

KW - Axonal transport

KW - experimental diabetic neuropathy

KW - gangliosides

UR - http://www.scopus.com/inward/record.url?scp=0022656779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022656779&partnerID=8YFLogxK

U2 - 10.1007/BF00454886

DO - 10.1007/BF00454886

M3 - Article

C2 - 2423405

AN - SCOPUS:0022656779

VL - 29

SP - 254

EP - 258

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 4

ER -